Fund Holdings — BIOS Capital Management, LP

Total Portfolio Value:
$34.17M
Total Bought:
$0
Total Sold:
$801.7K
Net Transaction:
-$801.7K
Notable People:
Bios Advisors Gp, Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Opus Genetics, Inc.(IRD)3,683,4293,683,4290$15.14M$17.83M52.17%+$2.69M
Actuate Therapeutics Inc10,049,99610,049,9960$15.38M$7.84M22.94%-$7.54M
Cognition Therapeutics, Inc.(CGTX)6,000,0006,000,0000$6.90M$5.76M16.86%-$1.14M
Rein Therapeutics Inc.(RNTX)2,982,3752,982,3750$3.10M$2.40M7.02%-$703.8K
Lantern Pharma Inc.(LTRN)249,397235,895-13,502$1.04M$238.3K0.70%-$801.7K
In8bio Inc80,95780,9570$114.1K$107.7K0.32%-$6.5K
Page 1 of 1
BIOS Capital Management, LP — 13F Holdings — Q3 2026 | TickerTrail